Hainan Shuangcheng Pharmaceuticals (002693.SZ): Injection-grade Bortezomib ANDA has obtained market approval from the US FDA.

16:24 18/12/2025

ST Shuangcheng (002693.SZ) announced that the company has recently received a notification from the U.S. Food and Drug Administration (FDA) that its Abbreviated New Drug Application (ANDA) for injection grade Bortezomib has been approved. The FDA conducted a comprehensive technical review of the ANDA application submitted by the company and determined that the company's product is bioequivalent and therapeutically equivalent to the reference drug.

Hainan Shuangcheng Pharmaceuticals (002693.SZ) announced that the company has recently received a notification from the Food and Drug Administration (FDA) of the United States that the Abbreviated New Drug Application (ANDA) for injection of Bortezomib submitted by the company to the FDA has been approved. The FDA conducted a comprehensive technical review of the ANDA application for injection of Bortezomib submitted by the company, and determined that the company's product is bioequivalent and therapeutically equivalent to the original drug.

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.